Elminda
Healthcare Software · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1100 Military Rd, Kenmore, New York, 142...Phone Number
(224) 888-0060Website
www.elminda.comRevenue
$5.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Elminda
Firefly Neuroscience specializes in advanced brain health analytics through its FDA-cleared technology, Brain Network Analytics (BNA). The BNA utilizes AI-driven assessments to provide objective measurements of brain activity, aiding healthcare professionals in diagnosing and managing cognitive disorders. Targeting healthcare providers, patients, and investors, Firefly aims to enhance patient outcomes and operational efficiency in neurological care. With a proprietary database and advanced AI, Firefly is positioned to lead in neurophysiological assessment and biomarker development.Explore more
Elminda Org Chart
SM
DevOps Engineer
OL
Senior Data Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elminda your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Elminda has new funding data
Product Launch: Get notified when Elminda launches new products
Click to see if Elminda had a recent Job posting/layoffs
Earning: See what the market has to say on Elminda recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Elminda
Check out if Elminda is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Elminda, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Elminda has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Elminda
Find more new buyers
Compare Similar Companies to Elminda
Compare insights from companies similar to Elminda, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Elminda is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Elminda is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Elminda.
Elminda financials insights
Gather financial insights about Elminda, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series C
$28M
Elminda Tech Stack
A closer look at the technologies used by Elminda
Elminda News & Media
European Commission Backs elminda's Breakthrough in Depression Treatment
HERZLIYA, Israel, March 7, 2019 /PRNewswire/ -- elminda Ltd, a leading brain technology company, was awarded by the European Commission multi-million € to bring its breakthrough technology to European patients suffering from depression. Over 50 million Europeans are suffering from...
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Elminda
Sign Up For FreeTo access detailed company insights
Firefly Neuroscience specializes in advanced brain health analytics through its FDA-cleared technology, Brain Network Analytics (BNA). The BNA utilizes AI-driven assessments to provide objective measurements of brain activity, aiding healthcare professionals in diagnosing and managing cognitive disorders. Targeting healthcare providers, patients, a... Read More
